Skip to main content
SpringerLink
Log in

Transdermales Estradiol als Add-on-Therapie der Schizophrenie

Additive Hormongabe verbessert Schizophreniesymptome bei Frauen

  • Journal club
  • Published:
InFo Neurologie + Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

© Weiser M et al. JAMA Psychiatry 2019; doi: 10.1001/jamapsychiatry.2019.1842

Referenzen

  1. Liu Y et al. Front Endocrinol 2019; 10: 801

  2. Laliberte F et al. Menopause 2018; 25: 1297-305

    Article  Google Scholar 

  3. Soria V et al. Psychoneuroendocrinology 2018; 93: 8-19

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie, Psychosomatik und Psychotherapie, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt, Deutschland

    Sarah Kittel-Schneider

Authors
  1. Sarah Kittel-Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Kittel-Schneider.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kittel-Schneider, S. Additive Hormongabe verbessert Schizophreniesymptome bei Frauen. InFo Neurologie 22, 14–15 (2020). https://doi.org/10.1007/s15005-020-1291-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-020-1291-8

Search

Navigation